Your browser doesn't support javascript.
loading
Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling.
Parra-Guillen, Zinnia P; Sancho-Araiz, Aymara; Mayawala, Kapil; Zalba, Sara; Garrido, Maria J; de Alwis, Dinesh; Troconiz, Iñaki F; Freshwater, Tomoko.
Affiliation
  • Parra-Guillen ZP; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
  • Sancho-Araiz A; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Mayawala K; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
  • Zalba S; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Garrido MJ; Quantitative Pharmacology and Pharmacometrics Immune/Oncology (QP2-I/O), Merck & Co., Inc., Rahway, New Jersey, USA.
  • de Alwis D; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
  • Troconiz IF; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Freshwater T; Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
Clin Pharmacol Ther ; 114(3): 623-632, 2023 09.
Article in En | MEDLINE | ID: mdl-37170933
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Oncolytic Viruses / Oncolytic Virotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Oncolytic Viruses / Oncolytic Virotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2023 Type: Article Affiliation country: Spain